English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Friday, May 3, 2024
Press Releases for Tuesday, November 30, 2021
艾伯科技公布2021年中期业绩
23:32 HKT/SGT
艾伯科技公佈2021年中期業績
23:31 HKT/SGT
IBO Technology Announces 2021 Interim Results
23:30 HKT/SGT
中国抗体公布旗舰产品SM03完成在中国III期临床试验招募
20:52 HKT/SGT
中國抗體公佈旗艦產品SM03完成在中國III期臨床試驗招募
20:51 HKT/SGT
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
20:50 HKT/SGT
三菱自動車、ラリーアート復活第一弾となる特別仕様車をタイで発表
18:00 HKT/SGT
Mitsubishi Motors Launches Ralliart Special Editions in Thailand
16:37 HKT/SGT
顺丰同城开启招股 近三年收入复合年增速高达120.8%
16:33 HKT/SGT
順豐同城開啟招股 近三年收入複合年增速高達120.8%
16:32 HKT/SGT
实时配送需求强烈 顺丰同城今起招股
16:29 HKT/SGT
即時配送需求強烈 順豐同城今起招股
16:28 HKT/SGT
顺丰同城今起招股 一手入场费3,628港元
16:23 HKT/SGT
順豐同城今起招股 一手入場費3,628港元
16:22 HKT/SGT
黃春華基金會向母校武漢大學捐贈4,000萬美元 創造該校有史以來個人捐贈最高紀錄
16:03 HKT/SGT
Charles Huang Foundation Makes Record-Breaking US$40 Million Donation to His Alma Mater, Wuhan University
16:02 HKT/SGT
日立、電力広域的運営推進機関から容量市場向けシステムを受注
16:00 HKT/SGT
エーザイとFCNT、認知症との共生と予防に向けた業務提携契約を締結
13:00 HKT/SGT
エーザイ、第75回米国てんかん学会年次総会にてペランパネルおよびE2730に関する最新データを発表
13:00 HKT/SGT
コベルコ建機とNEC、建設機械の遠隔操作の普及に向けた技術開発協定を締結
11:00 HKT/SGT
Eisai and FCNT Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia
09:13 HKT/SGT
Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting
08:56 HKT/SGT
业绩增长强劲母公司顺丰控股鼎力加持 顺丰同城赴港IPO
08:41 HKT/SGT
業績增長強勁母公司順豐控股鼎力加持 順豐同城赴港IPO
08:40 HKT/SGT
医思健康收购香港连锁牙科服务公司
08:37 HKT/SGT
醫思健康收購香港連鎖牙科服務公司
08:36 HKT/SGT
EC Healthcare Acquires Hong Kong Dental Services Chain
08:35 HKT/SGT
医思健康公布2021/22年度中期业绩
08:27 HKT/SGT
醫思健康公佈2021/22年度中期業績
08:26 HKT/SGT
EC Healthcare Announces FY2021/22 Interim Results
08:25 HKT/SGT
ACN Search:
CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575